Untitled

Loading Events

« All Webinars

“Implementing Next-generation Sequencing for Precision Oncology Testing”

Fisher Scientific* presents….”Implementing Next-generation Sequencing for Precision Oncology Testing”

According to a recent study by the Tufts Center for the Study of Drug Development, the majority of cancer treatments in development have an associated genomic biomarker—a trend that’s expected to increase in the coming years. With this evolution in the clinical oncology landscape, academic medical centers and hospital systems alike have adopted diagnostic precision medicine tools like next generation sequencing (NGS), which enables labs to rapidly and simultaneously test multiple genomic biomarkers from just a few nanograms of precious tumor tissue.  As the number of clinically significant biomarkers continues to expand, this testing will continue to play a critical role in cancer diagnosis and treatment.

In this P.A.C.E.-accredited webinar, Brian Piening, Phd, will highlight the clinical and economic considerations for implementing an NGS-based personalized medicine program and discuss case studies that demonstrate the benefits of determining the genomic profiles of a variety of cancer types.

Learning Objectives:

  • Evaluate the process of deciding whether to implement NGS in a clinical pathology lab
  • Describe the available testing strategies and chemistries
  • Review case studies in which NGS is uniquely suited to provide novel clinical insights

Presenter:

Brian Piening, Ph.D. | Associate Director | Providence St. Joseph Health (PSJH) Molecular Genomics Laboratory | Assistant Member and Head of the Tumor Immunogenomics Laboratory | Earle A. Chiles Research Institute & Providence Cancer Center

This webinar is produced by Whitehat Communications, a provder of continuing education programs i clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.

Unless otherwise noted, P.A.C.E. accreditation will expire six months after the live webinar.

*NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.